Search results

198 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Researchers clarify role of mutations in glioblastoma
In a preclinical study, researchers led by UNC Lineberger's Ryan Miller, MD, PhD, investigated whether the location of where the mutation occurred within the sequence of the PIK3CA gene affected the mutation’s ability to help drive cancerous growth. They also evaluated whether the location of the mutation would affect the cancer's response to certain treatments.
Located in News
Located in Newsroom / UNC Lineberger in the News
Anders, Wang selected for American Society of Clinical Oncology Leadership Development Program
UNC Lineberger Comprehensive Cancer Center’s Carey K. Anders, MD, and Andrew Z. Wang, MD, have been selected to participate in the 2018-2019 American Society of Clinical Oncology Leadership Development Program.
Located in Newsletters / / Honors and Awards / 2018
LLS awards Wang Career Development Program Scholar Grant
The Leukemia & Lymphoma Society has awarded UNC Lineberger’s G. Greg Wang, PhD, a five year, $550,000 Career Development Program Scholar Grant to support his research to decipher and target acute myeloid leukemia cell dependency and epigenetic mutations.
Located in Newsletters / / Honors and Awards / 2018
Located in Newsroom / UNC Lineberger in the News
UNC Lineberger hosts delegation from Malawi
A team of Malawian health and government officials met with UNC health and university leaders, researchers and clinical staff across three days to prepare for the opening of the first dedicated cancer center in Malawi.
Located in News
Located in Newsroom / UNC Lineberger in the News
Former NFL linebacker encourages cancer survivors to find joy in each day
UNC Lineberger's Cancer Survivors Day was held at The William and Ida Friday Center for Continuing Education in Chapel Hill on June 9. The day’s events included presentations and activities for survivors on exercise, clinical trials, and support programs for patients’ caregivers as well as lunch, art activities and dancing.
Located in News
Strahl earns MIRA award from NIH
The National Institute of General Medical Sciences awarded UNC Lineberger's Brian Strahl, PhD, $1.9 million over five years to continue investigating the detailed mechanisms of gene expression and chromatin, which are crucial to various diseases, especially cancers.
Located in Newsletters / / Honors and Awards / 2018
Bladder cancer model could pave the way for better drug efficacy studies
In the journal Cancer Research, UNC Lineberger’s William Y. Kim, MD, Benjamin G. Vincent, MD, and colleagues reported they have developed a mouse model of luminal bladder cancer, one of the two subtypes of advanced bladder cancer. The researchers said this model may help them to determine which patients may respond to immunotherapy treatments called checkpoint inhibitors.
Located in News